Literature DB >> 34508696

The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy.

Gang Wei1, Honglin Sun1, Kai Dong2, Libing Hu3, Qi Wang4, Qian Zhuang5, Yan Zhu2, Xianjing Zhang1, Yaodi Shao1, Huiru Tang4, Zhenfei Li5, Suzhen Chen1, Junxi Lu1, Yibing Wang6, Xinxin Gan2, Tao P Zhong7, Dingkun Gui1, Xiaoyong Hu1, Linhui Wang8, Junli Liu9.   

Abstract

Clear cell renal cell carcinoma (ccRCC) preferentially invades into perinephric adipose tissue (PAT), a process associated with poor prognosis. However, the detailed mechanisms underlying this interaction remain elusive. Here, we describe a bi-directional communication between ccRCC cells and the PAT. We found that ccRCC cells secrete parathyroid-hormone-related protein (PTHrP) to promote the browning of PAT by PKA activation, while PAT-mediated thermogenesis results in the release of excess lactate to enhance ccRCC growth, invasion, and metastasis. Further, tyrosine kinase inhibitors (TKIs) extensively used in the treatment of ccRCC enhanced this vicious cycle of ccRCC-PAT communication by promoting the browning of PAT. However, if this cross-communication was short circuited by the pharmacological suppression of adipocyte browning via H89 or KT5720, the anti-tumor efficacy of the TKI, sunitinib, was enhanced. These results suggest that ccRCC-PAT cross-communication has important clinical relevance, and use of combined therapy holds great promise in enhancing the efficacy of TKIs.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PKA; PTHrP; adipocytes browning; cell-to-cell communication; clear cell renal cell carcinoma; lactate; lung metastasis; tyrosine kinase inhibitors

Mesh:

Substances:

Year:  2021        PMID: 34508696     DOI: 10.1016/j.cmet.2021.08.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  9 in total

1.  Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis.

Authors:  Yuenan Liu; Jun Wang; Yi Shou; Wenjie Xu; Ziwei Huang; Jiaju Xu; Kailei Chen; Jingchong Liu; Di Liu; Huageng Liang; Hongmei Yang; Xiaoping Zhang
Journal:  Cell Death Dis       Date:  2022-07-04       Impact factor: 9.685

Review 2.  Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View.

Authors:  Miriam Lee-Rueckert; Jani Lappalainen; Petri T Kovanen; Joan Carles Escola-Gil
Journal:  Front Cardiovasc Med       Date:  2022-02-14

3.  Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cortney Steele; Kristen Nowak
Journal:  Kidney Dial       Date:  2022-03-04

4.  Lactic Acid Metabolism and Transporter Related Three Genes Predict the Prognosis of Patients with Clear Cell Renal Cell Carcinoma.

Authors:  Tuanjie Guo; Jian Zhang; Tao Wang; Zhihao Yuan; Heting Tang; Dongliang Zhang; Siteng Chen; Xiang Wang
Journal:  Genes (Basel)       Date:  2022-03-30       Impact factor: 4.141

5.  T-stage-specific abdominal visceral fat, haematological nutrition indicators and inflammation as prognostic factors in patients with clear renal cell carcinoma.

Authors:  Hao Guo; Yumei Zhang; Heng Ma; Peiyou Gong; Yinghong Shi; Wenlei Zhao; Aijie Wang; Ming Liu; Zehua Sun; Fang Wang; Qing Wang; Xinru Ba
Journal:  Adipocyte       Date:  2022-12       Impact factor: 4.534

Review 6.  The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.

Authors:  Xinpeng Yin; Yuan Chen; Rexiati Ruze; Ruiyuan Xu; Jianlu Song; Chengcheng Wang; Qiang Xu
Journal:  Signal Transduct Target Ther       Date:  2022-09-16

7.  A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma.

Authors:  Aimin Jiang; Xiaofeng Wu; Desheng Wang; Anbang Wang; Kai Dong; Bing Liu; Le Qu; Peng Luo; Jian Wang; Qiang Tong; Linhui Wang
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

8.  Aging-based molecular classification and score system in ccRCC uncovers distinct prognosis, tumor immunogenicity, and treatment sensitivity.

Authors:  Maoshu Zhu; Chaoqun Huang; Xinhong Wu; Ying Gu; Xiaoxu Hu; Dongna Ma; Weimin Zhong
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

9.  Development and validation of a novel necroptosis-related score to improve the outcomes of clear cell renal cell carcinoma.

Authors:  Ji Chen; Qiqi Tao; Zhichao Lang; Yan Jin; Guanqi Chen; Xinling Li; Zhixian Yu; Yeping Li
Journal:  Front Genet       Date:  2022-09-12       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.